Thalidomide (HAL) maintenance following high-dose melphalan with autologous stem cell transplant (ASCT) for myeloma.

被引：0
|
作者：
Chang, Julie E. [1 ]
Juckett, Mark B. [1 ]
Kahl, Brad. S. [1 ]
Mitchell, Teri L. [1 ]
Gangnon, Ronald E. [1 ]
Callander, Natalie S. [1 ]
Longo, Walter L. [1 ]
机构：
[1] Univ Wisconsin, Dept Hematol & Bone Marrow Transplantat, Madison, WI USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.5455.5455
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5455
引用
收藏
页码：459B / 459B
页数：1
相关论文
共 50 条
  • [31] High-Dose Therapy (HDT) with Melphalan and Autologous Stem Cell Transplantation (ASCT) for Patients Older Than 70 Years with Multiple Myeloma
    Brockhoff, Hendrik
    zum Bueschenfelde, Christian Meyer
    Ayoub, Murwan
    Goldschmidt, Hartmut
    Salwender, Hans-Juergen
    BLOOD, 2016, 128 (22)
  • [32] Impact of oral mucositis on outcomes of multiple myeloma patients treated with high-dose melphalan conditioning and autologous stem cell transplantation (ASCT).
    Jaguar, Graziella Chagas
    Rodrigues, Gustavo Henrique
    Guollo, Andre
    Camandoni, Vanessa Oliveira
    Magalhaes, Leila Maria
    Melo, Pessoa
    Alves, Fabio Abreu
    Cordeiro Lima, Vladmir Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [33] Use of pegfilgrastim after high-dose melphalan and autologous peripheral blood stem cell transplant in multiple myeloma patients
    Messina, G
    Martino, M
    Console, G
    Praticò, G
    Massara, E
    Moscato, T
    Pucci, G
    Irrera, G
    Callea, V
    Quartarone, E
    Stelitano, C
    Iacopino, P
    BONE MARROW TRANSPLANTATION, 2006, 37 : S306 - S306
  • [34] Pharmacokinetic-Pharmacodynamic Model of Neutropenia in Patients With Myeloma Receiving High-Dose Melphalan for Autologous Stem Cell Transplant
    Cho, Yu Kyoung
    Irby, Donald J.
    Li, Junan
    Sborov, Douglas W.
    Mould, Diane R.
    Badawi, Mohamed
    Dauki, Anees
    Lamprecht, Misty
    Rosko, Ashley E.
    Fernandez, Soledad
    Hade, Erinn M.
    Hofmeister, Craig C.
    Poi, Ming
    Phelps, Mitch A.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2018, 7 (11): : 748 - 758
  • [35] The Role of High-Dose Melphalan and Autologous Stem Cell Transplant in the Rapidly Evolving Era of Modern Multiple Myeloma Therapy
    Voorhees, Peter M.
    Usmani, Saad Z.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (09) : 719 - 728
  • [36] Cardiac transplant followed by high-dose melphalan and autologous stem cell transplantation (ASCT) for patients with AL amyloidosis and severe heart failure
    Dey, Bimalangshu R.
    Spitzer, Thomas R.
    MacGillivray, Thomas E.
    Chung, Stephen S.
    Dec, G. W.
    Seldin, David C.
    McAfee, Steven L.
    Ballen, Karen
    Attar, Eyal
    Skinner, Martha
    Madsen, Joren C.
    Semigran, Marc J.
    BLOOD, 2007, 110 (11) : 225A - 225A
  • [37] Autologous stem cell transplant for multiple myeloma: Impact of melphalan dose on the transplant outcome
    Kumar, Lalit
    Sahoo, Ranjit Kumar
    Kumar, Sudhir
    Baa, Annie K. K.
    Tansir, Ghazal
    Pathak, Neha
    Malik, Prabhat S. S.
    Sharma, Om Dutt
    Mathew, Anisha
    Jha, Ankit
    Gupta, Ritu
    Sharma, Atul
    Biswas, Ahitagni
    Kumar, Rakesh
    Thulkar, Sanjay
    Malik, Soumyaranjan
    Dutt, Ashish
    AIIMS Myeloma Grp
    LEUKEMIA & LYMPHOMA, 2023, 64 (02) : 378 - 387
  • [38] A META-ANALYSIS OF OVERALL SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE MAINTENANCE AFTER HIGH-DOSE MELPHALAN AND AUTOLOGOUS STEM CELL TRANSPLANT
    McCarthy, P. L.
    Palumbo, A.
    Holstein, S. A.
    Lauwers-Cances, V.
    Petrucci, M. T.
    Richardson, P. G.
    Hulin, C.
    Tosi, P.
    Anderson, K. C.
    Caillot, D.
    Magarotto, V.
    Moreau, P.
    Marit, G.
    Yu, Z.
    Attal, M.
    HAEMATOLOGICA, 2016, 101 : 2 - +
  • [39] Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy in Patients with Relapsed Multiple Myeloma.
    Mikhael, Joseph R.
    Zadeh, Sahar
    Stewart, A. Keith
    Chen, Christine
    Trudel, Suzanne
    Kukreti, Vishal
    Winter, Andrew
    Franke, Norman
    Reece, Donna E.
    BLOOD, 2009, 114 (22) : 501 - 501
  • [40] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Alexandra Gomez-Arteaga
    Tomer M. Mark
    Danielle Guarneri
    Paul J. Christos
    Usama Gergis
    June D. Greenberg
    Jingmei Hsu
    Sebastian A. Mayer
    Ruben Niesvizky
    Roger N. Pearse
    Adrienne A. Phillips
    Adriana Rossi
    Morton Coleman
    Koen van Besien
    Tsiporah B. Shore
    Bone Marrow Transplantation, 2019, 54 : 2027 - 2038
12345